Klotho Neurosciences, Inc. (KLTO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.48
• Market Cap: $30.91M
• EPS: $-0.30
• 52-Week High: $2.45
• 52-Week Low: $0.11

Market Sentiment

Klotho Neurosciences, Inc. currently has a Neutral sentiment score of 0.13.

About Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. is an innovative biopharmaceutical company based in Omaha, Nebraska, committed to developing transformative therapies for neurological and age-related disorders as well as specialty diagnostics. With a strong focus on research excellence and a vision to address significant unmet medical needs, Klotho is poised to revolutionize treatment paradigms within the neurology sector. The company's dedication to pioneering solutions underscores its role as a key player in the...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Klotho Neurosciences, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KLTO pay dividends?

Klotho Neurosciences, Inc. (KLTO) does not currently pay a regular dividend.

What is KLTO's market cap?

Klotho Neurosciences, Inc. (KLTO) has a market capitalization of $30.91M with a current stock price of $0.48.